Skip to main content

Breaking News: Endexx Adds 2,800 Stores and 20 New States in December with 2 Fortune 50 Mass Retail Stores

Written by Customer Service on . Posted in Public Companies.

Endexx continues its march to reach 20,000 major retail stores

WASHINGTON, Dec. 16, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Endexx Corporation (OTC: EDXC) (the “Company”), a provider of innovative hemp-derived CBD (“cannabidiol”) wellness and health products, announces the Company has surpassed its current store count goal after adding 2,800 stores in the month of December. As previously announced, Endexx recently expanded into 1,000 stores of a major Food/Drug/Mass (“FDM”) retailer chain, continuing an upward trend to place the Company’s product line in stores nationwide.

The Company has been keeping up with and utilizing new CBD law changes to navigate the landscape in a targeted approach to find promising growth opportunities. The proposed federal CBD Product Safety & Standardization Act of 2021, recently announced by a bipartisan group of U.S. Representatives, may help create standards that advance this valuable commodity of premium CBD products like those provided by Endexx Corporation.

Now in 44 states, Endexx aims to have its products in 20,000 stores, which management believes is a realistic goal, well within reach of the Company by the end of 2022. Endexx features products with controlled dosing, targeted delivery, functional plant-based ingredients and advanced formulas. The Company believes this dedication to quality products offers an experience that customers will enjoy.

The success of CBD-focused Endexx products is largely thanks to strong demand and recurring orders placed by major FDM stores. Purchase orders are arriving daily from major retailers and have been accelerating due to consumer demand and sales growth. The Company’s products are also available to consumers nationwide in mass retail pharmacy chains. Endexx recently welcomed Blesswell™ as a new addition to its brand profile. As providers of body, beard, and face solutions to the Ultra-Luxe self-care brand, Blesswell™ aims to make top-shelf grooming products available to every man.

As the health and wellness industry is positioned to grow at 6% annually and surpass $6 billion in revenue by 2025, the Blesswell™ wellness brand has its sights on making a strong impact in the CBD marketplace. Having a post-Covid presence in the massive FDM retail space is a significant step in bringing this wellness brand to a nationwide audience throughout North America.

Pioneers in the industry since 2014, Endexx will continue its convenience store rollout of CBD Unlimited as it further cements its place in the retail landscape.

To receive a copy of Endexx’s Investor Presentation Deck, please send an email request to endexx@endexx.com.

About BLESSWELL™
BLESSWELL™ solidifies its entrance into the CBD health and wellness arena by way of premium body, beard and face solutions. The clean cannabis-minded men’s grooming line is designed to be an essential toolkit for a man’s complete at-home, self-care needs. The eco-friendly, clean line of products features a variety of natural elixirs from beard oils, shaving creams, face cleansers, and body washes amongst other nutrient-rich skin savers — all of which are infused with 300mg CBD.

For more: blesswell.co

About Endexx Corporation 
Endexx Corporation, through its operating division CBD Unlimited Inc., develops and distributes all-natural CBD products derived from the cannabis Sativa plant (Hemp), containing less than 0.01% THC. Under its four major brands: CBD Unlimited, Phytobites, Maggie’s, and BlessWell, its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. PhytoBites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work to provide accuracy in dosage and delivery of optimal absorption per serving.

For More:
Endexx.com
Blesswell.co
Cbdunlimited.com

Safe Harbor Statement:
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief, or current expectations of the company, its directors, or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions, and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.

Company Contact:
Investor Relations
IR@endexx.com
480-595-6900

Corporate Communications:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.